Comparison of Thermo-plastic Versus Carbon Foot Ankle Orthosis to Improve Gait and Reduce Fatigue in Post-stroke Patients: a Biomechanical and Neurophysiological Study

Not Applicable

Completed

• Conditions: Hemiparesis;Poststroke/CVA; Gait, Hemiplegic
• Interventions: Device: Ankle Foot orthosis (AFO)

• Registration Number: NCT04323943
• Lead Sponsor: Thuasne

Brief Summary

Approximately 20% of stroke survivors have difficulties to dorsiflex the ankle and clear the ground during walking. This impairment, termed as "foot drop", is caused by an association of weak dorsiflexors and increased spasticity and stiffness of the plantar-flexors. As a consequence, walking performances are reduced and energy cost of walking is deteriorated. This may increase performance fatigability, as the locomotion will be realized at a higher percentage of the subjects' capacities. In order to overcome these issues, different treatments are proposed. One of the most conventional solutions are the use of ankle foot orthosis (AFO) and it is the most commonly prescribed device used to compensate for "foot drop". There is a very large choice of AFO on the market which can be proposed to patients with foot drop.

The aim of this study is thus to assess the mechanical effects of using a manufactured carbon AFO in by comparison to a custom-made thermo-plastic AFO on walking capacity (distance and energy cost), fatigue and "foot drop" control throughout the gait phase in patients with hemiparetic stroke.

Detailed Description

Not available

Study Timeline

• Study First Submitted: 2020-03-19
• Study First Submitted QC: 2020-03-26
• Study First Posted: 2020-03-27
• Study Start: 2020-09-07
• Primary Completion: 2021-11-23
• Study Completion: 2021-11-23
• Status Verified: 2022-01
• Last Update Submitted: 2022-01-10
• Last Update Posted: 2022-01-11

Recruitment & Eligibility

• Status: COMPLETED
• Sex: All
• Target Recruitment: 15

Inclusion Criteria

• Hemiparetic patients, walking with CM-AFO
• Diagnosis of a first stroke since at least 6 months with medical conditions of stroke known, treatment proposed, cardio-vascular and neurological state stabilized
• Foot drop observed during the swing phase of gait, requiring the use of a custom-made plastic orthosis that has been used for at least 3 months and used for less than 2 years
• Muscle spasticity not higher than grade 3 according to the Modified Ashworth Scale
• Sufficient motor ability and endurance to ambulate at least 15 m independently without AFO
• Patient who signed a consent
• Patients affiliated or entitled to a social security system.

Exclusion Criteria

• Patients who did not have brain MRI imaging after their stroke to confirm the diagnosis of stroke,
• Patients with an associated cerebellar syndrome,
• Patients with clinical brainstem involvement (cranial pair deficit),
• Patients with a neurological history other than stroke that has an impact on walking,
• Patients with unstable cardiovascular or respiratory disorders likely to induce gait disorders that may influence the performance of the tests to a greater extent than in the case of vascular hemiplegics,
• Patients with alcohol or drug dependence,
• Patients with psychiatric illness, cognitive impairment, uncontrolled disease/epilepsy, malignant pathology, renal impairment, unstable or decompensated diabetes, severe,
• Patients with a history of associated disabling systemic disease,
• Patients who refused to sign the written consent,
• Patients with a current pregnancy,
• Patients under court protection.

Study & Design

• Study Type: INTERVENTIONAL
• Study Design: CROSSOVER

Arm && Interventions

Group	Intervention	Description
Carbon-AFO (C-AFO)	Ankle Foot orthosis (AFO)	Manufactured carbon ankle foot orthosis (C-AFO) Sprystep (Thuasne) will be provided to patients. A familiarization with C-AFO will be performed before doing the tests.
Custom-made thermo-plastic orthosis (CM-AFO)	Ankle Foot orthosis (AFO)	Own custom-made thermo-plastic orthosis (CM-AFO) of patients. A familiarization will be performed also before doing the tests.

Primary Outcome Measures

Name	Time	Method
Distance walked during the 6 Minute Walk Test (6MWT)	Day : 14	Patient will performed three experimental session (14 days between each session) during wich the primary outcome will be assessed : one session while walking with C-AFO, one session while walking with CM-AFO, and one session while walking without AFO (randomized order).; 6 Minute Walk Test is a beneficial tool to evaluate walking endurance in patients with poststroke hemiparesis

Secondary Outcome Measures

Name	Time	Method
Energy cost	Day : 14	Energy cost will be assessed by oxygen consumption recorded during the 6MWT in the 3 conditions (C-AFO, CM-AFO, NO)
Muscular activity	Day: 14	Muscular activity will be assessed by electromyography (EMG) on different muscles (anterior tibial, gastroc medial, femoral). Muscular activity will be assessed before and after 6MWT during 5\*15m sessions
Angle	Day : 14	Angle (°) of ankle, knee and hip will be assessed in the 3 conditions before and after 6MWT during 5\*15 m sessions
Perceived fatigue	Day : 14	Perceived fatigue will be assessed by the Rated Perceived Exertion (RPE) scale before and after 6MWT. The RPE scale runs from 0 - 10. 0 is related to an easy activity and 10 (very, very heavy) is related to a very difficult activity.
Power	Day : 14	Power (watt) of ankle, knee and hip will be assessed in the 3 conditions before and after 6MWT during 5\*15 m sessions
Momentum	Day : 14	Momemtum (J rad-1) of ankle, knee and hip will be assessed in the 3 conditions before and after 6MWT during 5\*15 m sessions
Satisfaction related to the device	Day : 42	A satisfaction survey will be asked in order to assess the positioning of AFO, comfort, esthetic and global satisfaction of devices

Trial Locations

Locations (1)

Chu Saint Etienne; 🇫🇷 Saint-Étienne, France